Which has stronger valuation and earnings, DOCS or SDGR?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 8.43 $196.05M $0.85 35.88 Schrodinger $255.87M 7.47 -$103.26M -$0.74 N/A

Is DOCS or SDGR more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to DOCS or SDGR?

In the previous week, Doximity had 20 more articles in the media than Schrodinger. MarketBeat recorded 28 mentions for Doximity and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.61 beat Doximity's score of 0.18 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 2 Very Positive mention(s) 3 Positive mention(s) 23 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, WAY or SDGR?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.59 $112.09M $0.70 37.57 Schrodinger $255.87M 7.47 -$103.26M -$0.74 N/A

Is WAY or SDGR more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Schrodinger -20.98% -16.37% -8.19%

Does the media favor WAY or SDGR?

In the previous week, Waystar and Waystar both had 8 articles in the media. Waystar's average media sentiment score of 0.71 beat Schrodinger's score of 0.61 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, SDGR or HTFL?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 7.47 -$103.26M -$0.74 N/A Heartflow $176.03M 24.86 -$116.79M -$1.83 N/A

Is SDGR or HTFL more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Heartflow -55.82% -23.52% -18.66%

Does the media favor SDGR or HTFL?

In the previous week, Schrodinger had 4 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.79 beat Schrodinger's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, SDGR or CERT?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 7.47 -$103.26M -$0.74 N/A Certara $418.84M 3.50 -$1.60M -$0.45 N/A

Is SDGR or CERT more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Certara -16.75% 3.86% 2.65%

Does the media refer more to SDGR or CERT?

In the previous week, Schrodinger had 1 more articles in the media than Certara. MarketBeat recorded 8 mentions for Schrodinger and 7 mentions for Certara. Certara's average media sentiment score of 0.90 beat Schrodinger's score of 0.61 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, GDRX or SDGR?

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.48 $30.44M $0.04 86.25 Schrodinger $255.87M 7.47 -$103.26M -$0.74 N/A

Is GDRX or SDGR more profitable?

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Schrodinger -20.98% -16.37% -8.19%

Schrodinger (SDGR) Competitors

$25.89 -0.02 (-0.08%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$26.00 +0.11 (+0.41%)

As of 08:32 AM Eastern

Compare

SDGR vs. DOCS, WAY, HTFL, CERT, and GDRX

Should you buy Schrodinger stock or one of its competitors? Schrodinger's main competitors and comparable companies include Doximity (DOCS), Waystar (WAY), Heartflow (HTFL), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Schrodinger compare to Doximity?

Doximity (NYSE:DOCS) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Schrodinger	-20.98%	-16.37%	-8.19%

Doximity has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.62, suggesting that its share price is 62% more volatile than the broader market.

Doximity presently has a consensus price target of $31.95, suggesting a potential upside of 4.79%. Schrodinger has a consensus price target of $23.50, suggesting a potential downside of 9.23%. Given Doximity's higher probable upside, research analysts clearly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	8.43	$196.05M	$0.85	35.88
Schrodinger	$255.87M	7.47	-$103.26M	-$0.74	N/A

In the previous week, Doximity had 20 more articles in the media than Schrodinger. MarketBeat recorded 28 mentions for Doximity and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.61 beat Doximity's score of 0.18 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	2 Very Positive mention(s)	3 Positive mention(s)	23 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.2% of Doximity shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Doximity beats Schrodinger on 13 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Waystar?

Waystar (NASDAQ:WAY) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

In the previous week, Waystar and Waystar both had 8 articles in the media. Waystar's average media sentiment score of 0.71 beat Schrodinger's score of 0.61 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Schrodinger	-20.98%	-16.37%	-8.19%

Waystar currently has a consensus target price of $34.67, suggesting a potential upside of 31.81%. Schrodinger has a consensus target price of $23.50, suggesting a potential downside of 9.23%. Given Waystar's stronger consensus rating and higher possible upside, research analysts clearly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

79.1% of Schrodinger shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.59	$112.09M	$0.70	37.57
Schrodinger	$255.87M	7.47	-$103.26M	-$0.74	N/A

Waystar has a beta of 0.18, meaning that its stock price is 82% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.62, meaning that its stock price is 62% more volatile than the broader market.

Summary

Waystar beats Schrodinger on 12 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Heartflow?

Schrodinger (NASDAQ:SDGR) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Schrodinger has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, meaning that its share price is 173% more volatile than the broader market.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Heartflow	-55.82%	-23.52%	-18.66%

Schrodinger currently has a consensus target price of $23.50, suggesting a potential downside of 9.23%. Heartflow has a consensus target price of $46.25, suggesting a potential downside of 8.09%. Given Heartflow's stronger consensus rating and higher probable upside, analysts plainly believe Heartflow is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

79.1% of Schrodinger shares are held by institutional investors. 10.1% of Schrodinger shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Schrodinger had 4 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.79 beat Schrodinger's score of 0.61 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	7.47	-$103.26M	-$0.74	N/A
Heartflow	$176.03M	24.86	-$116.79M	-$1.83	N/A

Summary

Schrodinger beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Schrodinger compare to Certara?

Schrodinger (NASDAQ:SDGR) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Schrodinger presently has a consensus price target of $23.50, indicating a potential downside of 9.23%. Certara has a consensus price target of $8.82, indicating a potential downside of 8.14%. Given Certara's higher possible upside, analysts plainly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Schrodinger has a beta of 1.62, suggesting that its share price is 62% more volatile than the broader market. Comparatively, Certara has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Certara	-16.75%	3.86%	2.65%

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	7.47	-$103.26M	-$0.74	N/A
Certara	$418.84M	3.50	-$1.60M	-$0.45	N/A

In the previous week, Schrodinger had 1 more articles in the media than Certara. MarketBeat recorded 8 mentions for Schrodinger and 7 mentions for Certara. Certara's average media sentiment score of 0.90 beat Schrodinger's score of 0.61 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Certara beats Schrodinger on 9 of the 15 factors compared between the two stocks.

How does Schrodinger compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

GoodRx has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market.

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Schrodinger	-20.98%	-16.37%	-8.19%

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.25
Schrodinger	$255.87M	7.47	-$103.26M	-$0.74	N/A

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 10.1% of Schrodinger shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

GoodRx presently has a consensus target price of $4.23, indicating a potential upside of 22.53%. Schrodinger has a consensus target price of $23.50, indicating a potential downside of 9.23%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63

In the previous week, Schrodinger had 7 more articles in the media than GoodRx. MarketBeat recorded 8 mentions for Schrodinger and 1 mentions for GoodRx. GoodRx's average media sentiment score of 1.79 beat Schrodinger's score of 0.61 indicating that GoodRx is being referred to more favorably in the media.

Company	Overall Sentiment
GoodRx	Very Positive
Schrodinger	Positive

Summary

GoodRx beats Schrodinger on 10 of the 16 factors compared between the two stocks.

Get Schrodinger News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SDGR vs. The Competition

Export

Metric	Schrodinger	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.91B	$1.88B	$7.27B	$13.21B
Dividend Yield	N/A	3.94%	2.52%	22.89%
P/E Ratio	-34.99	18.10	202.90	19.69
Price / Sales	7.47	93.51	561.48	81.34
Price / Cash	N/A	32.13	77.16	53.04
Price / Book	5.24	6.05	10.61	6.03
Net Income	-$103.26M	-$19.09M	$3.50B	$380.34M
7 Day Performance	-5.13%	-0.62%	-2.89%	-2.34%
1 Month Performance	24.77%	-2.20%	-7.37%	-5.31%
1 Year Performance	33.25%	-20.67%	3.00%	-2.94%

Schrodinger Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SDGR Schrodinger	2.2947 of 5 stars	$25.89 -0.1%	$23.50 -9.2%	+31.4%	$1.91B	$255.87M	N/A	850	Analyst Forecast
DOCS Doximity	3.8202 of 5 stars	$30.49 0.0%	$31.95 +4.8%	N/A	$5.44B	$644.86M	35.87	880	Trending News
WAY Waystar	4.2493 of 5 stars	$26.65 -0.1%	$34.67 +30.1%	-27.3%	$5.12B	$1.10B	38.07	1,700
HTFL Heartflow	1.3005 of 5 stars	$50.56 +1.6%	$46.25 -8.5%	+51.5%	$4.33B	$212.07M	N/A	843
CERT Certara	1.9739 of 5 stars	$9.24 +1.2%	$8.60 -6.9%	-21.6%	$1.39B	$418.84M	N/A	1,576	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SDGR) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Schrodinger (SDGR) Competitors

SDGR vs. DOCS, WAY, HTFL, CERT, and GDRX

How does Schrodinger compare to Doximity?

Summary

How does Schrodinger compare to Waystar?

Summary

How does Schrodinger compare to Heartflow?

Summary

How does Schrodinger compare to Certara?

Summary

How does Schrodinger compare to GoodRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Schrodinger (SDGR) Competitors

SDGR vs. DOCS, WAY, HTFL, CERT, and GDRX

How does Schrodinger compare to Doximity?

Is DOCS or SDGR more profitable?

Which has more risk & volatility, DOCS or SDGR?

Do analysts rate DOCS or SDGR?

Which has stronger valuation and earnings, DOCS or SDGR?

Does the media refer more to DOCS or SDGR?

Do institutionals & insiders have more ownership in DOCS or SDGR?

Summary

How does Schrodinger compare to Waystar?

Does the media favor WAY or SDGR?

Is WAY or SDGR more profitable?

Do analysts recommend WAY or SDGR?

Do institutionals and insiders have more ownership in WAY or SDGR?

Which has stronger earnings and valuation, WAY or SDGR?

Which has more risk & volatility, WAY or SDGR?

Summary

How does Schrodinger compare to Heartflow?

Which has more volatility and risk, SDGR or HTFL?

Is SDGR or HTFL more profitable?

Do analysts rate SDGR or HTFL?

Do insiders and institutionals hold more shares of SDGR or HTFL?

Does the media favor SDGR or HTFL?

Which has stronger earnings and valuation, SDGR or HTFL?

Summary

How does Schrodinger compare to Certara?

Do analysts rate SDGR or CERT?

Which has more risk & volatility, SDGR or CERT?

Is SDGR or CERT more profitable?

Do institutionals & insiders believe in SDGR or CERT?

Which has preferable earnings & valuation, SDGR or CERT?

Does the media refer more to SDGR or CERT?

Summary

How does Schrodinger compare to GoodRx?

Which has more volatility & risk, GDRX or SDGR?

Is GDRX or SDGR more profitable?

Which has higher earnings and valuation, GDRX or SDGR?

Do insiders & institutionals have more ownership in GDRX or SDGR?

Do analysts rate GDRX or SDGR?

Does the media favor GDRX or SDGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools